Health Care & Life Sciences » Biotechnology | Global Blood Therapeutics Inc.

Global Blood Therapeutics Inc. | Key People and Executives

Ted W. Love
President, Chief Executive Officer & Director
Wendy L. Yarno
Independent Director
Glenn F. Pierce
Independent Director
Scott W. Morrison
Independent Director
Philip A. Pizzo
Independent Director
Deval L. Patrick
Independent Director
Mark L. Perry
Independent Director
Willie Lewis Brown
Independent Director
Charles J. Homcy
Independent Director
Ted W. Love
President, Chief Executive Officer & Director
Peter Radovich
Senior Vice President-Operations
Jeffrey S. Farrow
Chief Financial Officer
Jonathan Sorof
Senior Vice President-Medical & Regulatory affairs
Josh Lehrer
Senior Vice President-Clinical Development
David L. Johnson
Chief Commercial Officer
Jung E. Choi
Chief Business & Strategy Officer
Lesley Ann Calhoun
Chief Accounting Officer
Myesha Lacy
Vice President-Investor Relations & Communications
Julie Normart
Head-Media Relations
Matt Krause
Vice President-Human Resources
Heidi L. Wagner
Senior Vice President-Government Affairs & Policy
Tricia Borga Suvari
Chief Legal Officer
Wendy L. Yarno
Independent Director
Glenn F. Pierce
Independent Director
Scott W. Morrison
Independent Director
Philip A. Pizzo
Independent Director
Deval L. Patrick
Independent Director
Mark L. Perry
Independent Director
Willie Lewis Brown
Independent Director
Charles J. Homcy
Independent Director

About Global Blood Therapeutics

View Profile
Address
171 Oyster Point Boulevard
South San Francisco California 94080
United States
Employees -
Website http://www.gbt.com
Updated 07/08/2019
Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P.